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SUPPLEMENTARY INFORMATION 
 
to the manuscript of “Overexpression of transient receptor potential canonical type1 
(TRPC1) alters both store operated calcium entry and depolarization-evoked calcium 
signals in C2C12 cells” by Tamás Oláh et al. 
 
Supplementary Figure 1. 
Examination of the effect on SOCE of the extent of TRPC1 overexpression. (A) 
Western-blot analysis of TRPC1 in the transfected clones. The 87 kDa human isoform 
was expressed from the plasmid used for stable transfection. Clone 8 was showing the 
most significant overexpression, so this clone was used in most of the other experiments 
(referred to as TRPC1 on the other figures). Clone 10 and 11 were also used in some 
experiments. Changes in calcium concentration demonstrating SOCE were recorded 
following the re-establishing of the normal (1.8 mM) external calcium concentration 
([Ca2+]o) in TRPC1 overexpressing C2C12 clones ((B) clone 11, (C) clone 10). The 
internal calcium-stores were emptied by 4 µM thapsigargin (TG) in the absence of 
[Ca2+]o. Representative records of 2 independent cultures. (D) Maximal rate of rise and 
(E) amplitude of SOCE in myotubes overexpressing TRPC1 in different extents. 
Asterisks (*) indicate significant (p < 0.05) difference if compared to parental cells; 
paragraph signs (§) indicate significant (p < 0.05) difference if compared to mock-
transfected, while “and” signs (&) indicate significant (p < 0.05) difference if compared 
to TRPC1 overexpressing (clone 8) myotubes. Numbers in parentheses indicate the 
number of cells measured. 
 
Supplementary Figure 2. 
Immunocytochemical staining of 5-day-old C2C12 myotubes demonstrating the 
presence of proteins associated with calcium signaling. (A) Expression of STIM1 
protein in parental (left panel) and in TRPC1 overexpressing (right panel) C2C12 
myotubes. (B) Expression of Orai1 protein in parental (left panel) and in TRPC1 
overexpressing (right panel) C2C12 myotubes. Nuclei were stained with DAPI. 
Calibration is the same for all images. Original magnification was 40×. 
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Supplementary Figure 3. 
Immunocytochemical staining of 5-day-old C2C12 myotubes demonstrating the 
aggregation of STIM1 protein into puncta after store depletion caused by 4 µM 
thapsigargin for 30 minutes. On the right panel the zoom was 4×, on the same visual 
field as shown in the left panel. (A) Expression of STIM1 protein in parental C2C12 
myotubes. (B) Expression of STIM1 protein in mock-transfected C2C12 myotubes. (C) 
Expression of STIM1 protein in TRPC1 overexpressing C2C12 myotubes. Nuclei were 
stained with DAPI. Original magnification was 40×. 
 
Supplementary Figure 4. 
Effects of NFAT activity in parental and TRPC1 overexpressing myotubes. Cells 
were transfected with a HSP-NRE lacZ plasmid as described by Rosenberg and co-
workers [36] (a kind gift from E. Zádor). The transfected cells expressed β-
galactosidase from the plasmid in function of NFAT activity. The cells were fixed with 
4 ºC 0.5% glutaraldehyde (diluted in PBS) for 10 min, and then washed three times with 
PBS. Then 1 mg/ml X-Gal (5-bromo-4-chloro-3-indoyl-B-D-galactoside; from 
Invitrogen) was dissolved in reaction buffer (20 mM K4Fe(CN)6, 20 mM K3Fe(CN)6, 2 
mM MgCl2 in PBS, pH 7.8) and placed on the cells overnight. In the dependence of β-
galactosidase activity, the cells became blue. The stained cells were examined by a 
fluorescent microscope. 5-5 ROIs were selected on each myotube. Quantitative analysis 
was performed with ImageJ on 15 parental and 9 TRPC1 overexpressing myotubes 
(p<0.05; 57.5±1.4 AU, n=75 in parental and 46.1±2.6 AU, n=45 in TRPC1 
overexpressing myotubes). (A) Parental myotubes. (B) TRPC1 overexpressing 
myotubes. Original magnification was 10×. (C) Representative images of differentiating 
C2C12 cells on different days of culturing. Parental, mock-transfected and TRPC1 
overexpressing C2C12 myotubes were cultured under the same conditions. The 
proliferating solution was exchanged to differentiating solution on the 2nd day of 
culturing. Note the thinner diameter of the terminally differentiated myotubes in the 
TRPC1 overexpressing cultures compared to parental and mock-transfected cultures. 
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